Programming - BCVS Scientific Sessions 2021
NEW DATES: August 23–25, 2021 | A Virtual Experience
About this Meeting
The 16th annual BCVS 2021 Scientific Sessions has become the premier conference for molecular cardiovascular biology and disease. Sponsored by the American Heart Association Basic Cardiovascular Sciences Council, the world’s leading organization of cardiovascular scientists, the conference attracts leading researchers in fields such as microRNAs, cardiac gene and cell therapy, cardiac development and most recently tissue engineering and iPS cells.
Target Audience
- Basic cardiovascular scientists
- Molecular/cellular biologists
- Physiologists
- Translational investigators
- Clinical trialists
- Practicing cardiologists
- Cardiovascular nurses and pharmacists
Learning Objectives
At the conclusion of the conference, participants will be able to:
- Understand new developments in cardiovascular pathophysiology and implications for future therapeutics.
- Discuss the lasted research on cardiovascular inflammation and how this links to heart failure.
- Describe current knowledge gaps in research and understanding of cardiovascular disease.
- Recognize the basis of cardio-immunology and the link to cardio-oncology.
- Explain the potential role of and challenges involved in the use of big data analytics in precision medicine to guide treatment in cardiovascular disease including COVID-19 related injury.
BCVS 2021 Program Committee Members
Pilar Alcaide, MS, PhD, FAHA
Program Committee Chair
Tufts University School of Medicine
Sumanth Prabhu, MD, FAHA
Program Committee Vice-Chair
University of Alabama at Birmingham
Members
- John Calvert, PhD, Emory University School of Medicine
- Stefanie Dimmeler, PhD, Institute of Cardiovascular Regeneration Frankfurt
- Aikaterini Kontrogianni Konstan, PhD, University of Maryland Medicine
- Nicole Purcell, PhD, Huntington Medical Research Institute
- Gangjian Qin, MD, PhD, University of Alabama at Birmingham
- Hesham Sadek, MD, PhD, UT Southwestern Medical Center
- Farah Sheikh, PhD, University of California San Diego
- Akl Fahed, MD, MPH, Massachusetts General Hospital
2021 Preliminary Program
This section will be updated as speakers and presentations are confirmed. For a printable document, see the 2021 Schedule at a Glance (PDF).
Monday
- Time (all times are Central)
- Activity
- 11:00 - 11:15 a.m.
Early Career Opening Remarks
- 11:15 a.m. - 12:15 p.m.
Early Career Session 1: Next Best Thing in Cardiovascular Research
- 12:15 - 12:30 p.m.
Break/Exhibits
- 12:30 - 1:15 p.m.
Early Career Session 2: Next Best Thing in Cardiovascular Research
- 1:15 - 1:45 p.m.
Early Career Keynote
- 1:45 - 2:00 p.m.
Break/Exhibits
- 2:00 - 2:15 p.m.
Session 1: BCVS 2021 Opening Welcome
- 2:15 - 3:15 p.m.
Session 2A: Sarcomeric Cardiomyopathies: from Bedside to Bench and Back
Session 2B: Cardiac Repair and Tissue Engineering
- 3:15 - 3:30 p.m.
Break/Exhibits
- 3:30 - 4:30 p.m.
Moderated Poster Session 1A
Moderated Poster Session 1B
- 4:30 - 5:30 p.m.
Session 3A: Small RNAs, Exosomes and Extracellular Vesicles in Cardiovascular Disease
Session 3B: Cellular Reprogramming in Heart Failure
Tuesday
- Time (all times are Central)
- Activity
- 10:00 - 11:00 a.m.
Session 4: Women in Science Breakfast
- 11:00 a.m. - Noon
Session 5: Keynote Speaker
- Noon - 12:30 p.m.
Break/Exhibits
- 12:30 - 1:30 p.m.
Session 6A: COVID-19 and Myocardial Injury: Short- and Long-Term Cardiovascular Effects
Session 6B: Novel Disease Pathways in Cardiac Remodeling
- 1:30 - 2:30 p.m.
Moderated Poster Session 2A
Moderated Poster Session 2B
- 2:30 - 2:45 p.m.
Break/Exhibits
- 2:45 - 3:45 p.m.
Session 7: Outstanding Early Career Investigator Award Competition
- 3:45 - 4:00 p.m.
Break/Exhibits
- 4:00 - 5:00 p.m.
BCVS Mix & Mingle – Sponsored by Early Career Committee
Wednesday
- Time (all times are Central)
- Activity
- 10:00 - 11:00 a.m.
Session 8A: Bench to Bedside: Cardiovascular Disease Therapies Not Lost in Translation
Session 8B: Deconstructing the Heart with Multiscale Approaches
- 11:00 a.m. - Noon
Session 9A: HFpEF and HFrEF Heterogeneity and Precision Medicine
Session 9B: Cardiotoxicity of Cancer Therapeutics: Cardio-oncology Meets Immunology
- Noon - 12:30 p.m.
Break/Exhibits
- 12:30 - 1:30 p.m.
Moderated Poster Session 3A
Moderated Poster Session 3B
- 1:30 - 2:30 p.m.
Session 10A: Myocytes and Non- myocytes in Cardiac Hypertrophy
Session 10B: State of the Art: New insights in Cardiac Fibrosis and Inflammation
- 2:30 - 2:45 p.m.
Closing Address
Monday
- Time (all times are Central)
- Activity
- 11:00 - 11:15 a.m.
Early Career Opening Remarks
- 11:15 a.m. - 12:15 p.m.
Early Career Session 1: Next Best Thing in Cardiovascular Research
- 12:15 - 12:30 p.m.
Break/Exhibits
- 12:30 - 1:15 p.m.
Early Career Session 2: Next Best Thing in Cardiovascular Research
- 1:15 - 1:45 p.m.
Early Career Keynote
- 1:45 - 2:00 p.m.
Break/Exhibits
- 2:00 - 2:15 p.m.
Session 1: BCVS 2021 Opening Welcome
- 2:15 - 3:15 p.m.
Session 2A: Sarcomeric Cardiomyopathies: from Bedside to Bench and Back
Session 2B: Cardiac Repair and Tissue Engineering
- 3:15 - 3:30 p.m.
Break/Exhibits
- 3:30 - 4:30 p.m.
Moderated Poster Session 1A
Moderated Poster Session 1B
- 4:30 - 5:30 p.m.
Session 3A: Small RNAs, Exosomes and Extracellular Vesicles in Cardiovascular Disease
Session 3B: Cellular Reprogramming in Heart Failure
Tuesday
- Time (all times are Central)
- Activity
- 10:00 - 11:00 a.m.
Session 4: Women in Science Breakfast
- 11:00 a.m. - Noon
Session 5: Keynote Speaker
- Noon - 12:30 p.m.
Break/Exhibits
- 12:30 - 1:30 p.m.
Session 6A: COVID-19 and Myocardial Injury: Short- and Long-Term Cardiovascular Effects
Session 6B: Novel Disease Pathways in Cardiac Remodeling
- 1:30 - 2:30 p.m.
Moderated Poster Session 2A
Moderated Poster Session 2B
- 2:30 - 2:45 p.m.
Break/Exhibits
- 2:45 - 3:45 p.m.
Session 7: Outstanding Early Career Investigator Award Competition
- 3:45 - 4:00 p.m.
Break/Exhibits
- 4:00 - 5:00 p.m.
BCVS Mix & Mingle – Sponsored by Early Career Committee
Wednesday
- Time (all times are Central)
- Activity
- 10:00 - 11:00 a.m.
Session 8A: Bench to Bedside: Cardiovascular Disease Therapies Not Lost in Translation
Session 8B: Deconstructing the Heart with Multiscale Approaches
- 11:00 a.m. - Noon
Session 9A: HFpEF and HFrEF Heterogeneity and Precision Medicine
Session 9B: Cardiotoxicity of Cancer Therapeutics: Cardio-oncology Meets Immunology
- Noon - 12:30 p.m.
Break/Exhibits
- 12:30 - 1:30 p.m.
Moderated Poster Session 3A
Moderated Poster Session 3B
- 1:30 - 2:30 p.m.
Session 10A: Myocytes and Non- myocytes in Cardiac Hypertrophy
Session 10B: State of the Art: New insights in Cardiac Fibrosis and Inflammation
- 2:30 - 2:45 p.m.
Closing Address